Document Type : Original Article
Introduction
Orthognathic surgery is the surgical correction of congenital, developmental, or acquired deformities of the facial bones to restore anatomy and function (1). Although orthognathic surgery is considered relatively safe, more than 65 complications have been reported in one study, ranging from postoperative nausea and vomiting to death (2). Severe bleeding and subsequent prolonged recovery are also reported as common complications of orthognathic surgery (1, 3 and 4). The reason for this extensive bleeding is the extensive vascular network of the maxillofacial region and the difficulty of accessing the surgical site for hemostasis (3, 5). Several vessels may be exposed to maxillary osteotomy, leading to severe bleeding. These structures include the descending palatine artery, trigeminal venous network, sphenopalatine artery, and maxillary artery. Also, injury to the inferior alveolar artery, retromandibular vein, masseteric artery, or facial artery can lead to bleeding during mandibular osteotomy (1, 5). Several factors such as the duration of surgery, surgical method, anesthetic technique, hemostasis, and surgeon skill affect the amount of blood loss during surgery (5).
Blood loss in orthognathic surgery is usually calculated after wound closure. This is obtained by subtracting the volume of fluid used for irrigation from the total fluid content of the suction reservoir (7, 8). Other studies have also included the weight of surgical gauze and throat packing (9, 10), although this may underestimate blood loss because intra-tissue and maxillary sinus bleeding is not considered (3, 9). Hemoglobin and hematocrit levels are commonly used as indicators to determine the severity of blood loss and to decide whether to administer blood transfusion. In general, when hemoglobin is less than 6 g/dL or 30–40% of blood volume is lost, blood transfusion is indicated (1). However, blood transfusion can be associated with complications such as infection, prolonged hospital stay, and even death (1, 11). However, the amount of blood loss reported in different studies varies widely (1, 3, 5, 12-14). Careful planning of this surgery in advance and consideration of various considerations before surgery are essential (1). Accurate estimation and prediction of blood loss during orthognathic surgery is very important. The more accurate this estimation is, the more prepared the surgical team is to deal with potential risks during surgery and provides the surgeon and anesthesiologist with the necessary prognosis for the required treatments. The patient himself is also informed about the possibility of blood transfusion before surgery (15). Given the necessity of knowing the patient's condition during surgery, including the amount of blood loss, the present study investigated the rate of hemoglobin drop in patients undergoing orthognathic surgery.
Methods:
In this quasi-experimental study, which was approved with the ethics code IR.MUBABOL.REC.1403.043, patients over 18 years of age who underwent orthognathic surgery (Bilateral Sagittal Split Osteotomy (BSSO), Le Fort I, or both (Bimax) at Shahid Beheshti Hospital in Babol and Dr. Shariati Hospital in Tehran were selected and studied using a simple sampling method. Exclusion criteria included patients with hemophilia, von Willebrand disease, and an unpredictable complication during surgery (need for blood transfusion). In this study, considering a type 1 error of 0.05, a power of 0.8, an acceptable error of 100 ml, and based on the standard deviation of a similar study (15), a sample size of at least 34 people was considered according to the following formula.
Hemoglobin and hematocrit of the patients were measured and recorded before and 24 hours after surgery. Also, after the end of surgery, the amount of blood loss (milliliters) was recorded, which was obtained by subtracting the volume of fluid used for washing from the total fluid content in the suction reservoir. The increase in the weight of blood gases and pharyngeal pack was also added to this amount. The duration of surgery was also recorded.
Finally, the data were recorded in SPSS software (IBM, Armonk, New York) version 26 and, in addition to reporting the data by descriptive statistics indicators, Independent sample T-test and ANOVA tests were used to compare the decrease in hemoglobin and the amount of blood loss between the two genders and based on the type of surgery, and Pearson's correlation test was used to examine their relationship with the duration of surgery.A p<0.05 was considered statistically significant.
Results
In this study, 39 patients with a mean age of 27.54±5.72 years (range 18 to 40 years), of whom 17 (43.59%) were males who were studied. 5 of them (1 male and 4 females) underwent BSSO surgery, 4 (1 male and 3 females) underwent Le Fort I, and 30 (15 males and 15 females) underwent Bimax. The frequency of patients in the different groups based on the type of surgery and their gender did not have a statistically significant difference (P=0.334). In this study, the duration of surgery, hematocrit, and hemoglobin before and after surgery, the rate of hemoglobin loss, and the amount of blood loss were measured. The mean values of these variables were examined by type of surgery, which are shown in Table 1.
Table 1. Mean values and standard deviations of the studied variables by type of surgery
|
P-value* |
BSSO (Number= 5) |
The fort I (Number= 4) |
Bimax (Number= 30) |
Type of surgery |
|
<0.001 |
2.50±0.61 |
3.75±0.96 |
5.27±1.01 |
Surgery duration (hours) |
|
0.861 |
40.12±5.41 |
42.50±16.53 |
41.80±5.57 |
Hematocrit (percentage) |
|
0.587 |
13.28±1.83 |
13.10±1.24 |
13.90±1.83 |
Hemoglobin before surgery (g/dL) |
|
0.822 |
12.58±1.58 |
12.23±1.16 |
12±2.07 |
Hemoglobin after surgery (g/dL) |
|
0.01 |
0.70±0.17 |
0.87±0.17 |
1.88±0.97 |
Decrease in hemoglobin (g/dL) |
|
0.027 |
122±43.82 |
200±81.65 |
301.67±153.96 |
Amount of blood lost ((mL) |
As can be seen in Table 1, the mean variables of surgical duration (P<0.001), hemoglobin drop (P<0.001), and blood loss (P=0.27) were statistically significantly different based on the type of surgery. In examining the duration of surgery between different groups, it was found that the mean duration of Bimax surgery was significantly longer than Le Fort I (P=0.021) and BSSO (P<0.001); however, there was no statistically significant difference between the mean duration of Le Fort I and BSSO surgery (P=0.175).
In the study of the rate of hemoglobin loss in patients based on the type of surgery, it was also found that the hemoglobin loss in Bimax surgery was significantly higher than BSSO (P=0.035); but there was no statistically significant difference between Le Fort I and BSSO surgery (P=0.959) and Bimax and Le Fort I (P=0.125).
The average amount of blood lost was also statistically different between BSSO and Bimax surgeries (P=0.041), which was higher in Bimax surgery, but there was no statistically significant difference between Le Fort I and BSSO (P=0.714) and Bimax and Le Fort I (P=0.408).
The relationship between the duration of surgery and the rate of hemoglobin loss and the amount of blood lost is shown in Table 2.
Table 2. Relationship between surgical duration, blood loss and hemoglobin drop
|
Decrease in hemoglobin |
Lost blood |
Duration of surgery |
|
0.620 |
0.609 |
Correlation (r) |
|
<0.001 |
<0.001 |
P-value |
As can be seen in Table 2, there was a significant direct relationship between the duration of surgery and the decrease in hemoglobin (P < 0.001 and r = 0.62) and the amount of blood lost (P < 0.001 and r = 0.609).
Comparison of the mean values of the variables based on the gender of the patients is given in Table 3. In this study, the difference in hematocrit (P = 0.004) and hemoglobin before and after surgery (P < 0.001) was significant between male and female patients (so that their mean was higher in male patients) and the rest of the cases did not show a statistically significant difference (P > 0.05).
Table 3. Mean values and standard deviations of the studied variables by gender of patients
|
P-value |
Male (Number= 17) |
Female (Number= 22) |
Gender |
|
0.792 |
4.82±1.37 |
4.70±1.40 |
Surgery duration (hours) |
|
0.004 |
45.22±6.46 |
38.91±6.18 |
Hematocrit (percentage) |
|
<0.001 |
15.05±1.30 |
12.73±1.39 |
Hemoglobin before surgery (g/dL) |
|
<0.001 |
13.44±1.70 |
11.06±1.37 |
Hemoglobin after surgery (g/dL) |
|
0.929 |
1.61±0.97 |
1.64±1.04 |
Decrease in hemoglobin (g/dL) |
|
0.835 |
262.73±175.07 |
272.73±175.07 |
Amount of blood lost (mL) |
Discussion
Orthognathic surgery is generally considered a major surgery that requires hospitalization, close monitoring, and various interventions related to the patient's blood parameters. Severe bleeding followed by a long recovery period is a common side effect of orthognathic surgery, due to the extensive vascular network in the head and neck region. The results of a study conducted by Salma et al. in 2017 showed that 9% of patients undergoing orthognathic surgery required intraoperative blood transfusion, with 74% requiring 1 RBC unit and the rest requiring 2 RBC units (1)
According to the results of this study, the mean age of the subjects was 27.54±7.52 (range 18–40 years), of which 17 (43.59%) were males. In the present study, the analysis of information such as hematocrit, hemoglobin before and after surgery, hemoglobin loss, and blood loss between the two sexes showed that women and men had significant differences in hematocrit and hemoglobin before and after surgery; these were significantly lower in women than in men. Ueki et al. conducted a study in 2005 to investigate effective ways to reduce bleeding during orthognathic surgery. During the stages of this study, RBC, hemoglobin, and hematocrit were examined by gender, before and after surgery, and the results showed that these were significantly lower in women before and after surgery than in men (16). This could be due to the different physiology of women compared to men. In this study, there was no significant difference between the two sexes in terms of blood loss and hemoglobin loss. A study conducted by Salma et al. in 2017 to investigate the timing of surgical blood loss, hemoglobin drop, blood transfusion, and length of hospital stay in orthognathic surgery showed that the amount of blood loss in men was significantly higher than in women, which was inconsistent with the results of the present study (1); because men underwent more severe surgeries than women in that study. A study conducted by Thesum et al. in 2016 stated that there was no significant difference between males and females in terms of blood loss, which was consistent with the results of our study (7).
In this study, orthognathic surgery techniques (BSSO, Le Fort I, or Bimax) were also compared in terms of surgical time, hematocrit, and hemoglobin levels before and after surgery, hemoglobin loss, and blood loss. The results of the present study showed that the duration of Bimax surgery was significantly longer than BSSO and Le Fort I surgeries, but there was no significant difference between the durations of BSSO and Le Fort I surgeries. The results of a study conducted by Bowe et al. in 2021 showed that Bimax surgery had the longest duration, which was consistent with the results of our study. Also, the duration of Le Fort I surgery was slightly longer than BSSO, and it can be said that there was no significant difference and was consistent with the results of our study (17). Considering that simultaneous correction of the upper and lower jaws (Le Fort I, BSSO) is performed in Bimax surgery, it is expected that it will take longer than surgery on each jaw alone. Also, due to the greater complexity of maxillary surgery due to proximity to anatomical structures such as paranasal sinuses and nerves, this surgery (Le Fort I) requires more precision and time. On the other hand, the surgeon's skill and the use of more advanced techniques also affect the surgical time, and the lack of significant difference in this method in the present study may be due to this. According to the present study, the amount of blood loss and hemoglobin drop in Bimax surgery was significantly higher than in BSSO surgery. However, there was no significant difference between BSSO and Le Fort I surgeries, as well as between Bimax and Le Fort I surgeries. The results of a study conducted by Salma et al. in 2017 to investigate the surgical time of blood loss, hemoglobin drop, blood transfusion, and length of hospital stay in orthognathic surgery showed that patients undergoing Le Fort I surgery lost more blood than patients undergoing BSSO surgery, which was inconsistent with the results of our study. This discrepancy could be due to the larger sample size of their study. Factors such as the skill of the surgeon, preoperative precautions, and medications used to reduce bleeding may also explain this difference. In general, the amount of bleeding in Le Fort I surgery may be higher than in BSSO because the maxillary bone is usually spongier and has more blood vessels. This study also showed that patients undergoing combined surgery (BSSO+LI+GP) had more bleeding, which was consistent with the results of our study (1). Thesum et al. (2016) conducted a study to investigate the factors affecting the amount of blood loss during orthognathic surgery. In this study, the three-piece Le Fort I osteotomy, BSSO, and combined surgery were examined. The results showed that the treatment method had a significant effect on the amount of blood loss, and there was a significant difference between the two methods, which was different from our study, which only reported a difference in the amount of bleeding between the two surgical methods, Bimax and BSSO (7). The reason for the difference in results can be attributed to the difference in sample size, surgeon skill, and instruments used.
According to the present study, the duration of surgery was significantly associated with the amount of blood loss and hemoglobin loss, and these two factors increased with increasing surgical duration. A study by Salma et al. on patients who underwent BSSO, Le Fort I, or any combination of the two also showed that there was a significant relationship between the duration of surgery and the amount of blood loss, which was consistent with the results of the present study (1).
Therefore, factors affecting the amount of blood loss during maxillofacial surgeries, such as gender, surgical duration, and surgical technique, should be specifically considered and investigated by surgeons to control the intraoperative and postoperative complications in patients and provide them with a better treatment experience.
Conclusion
Comparison of orthognathic surgery techniques showed that Bimax surgery duration was longer than BSSO and Le Fort I, but there was no significant difference between BSSO and Le Fort I. The amount of blood lost during Bimax surgery was also greater than BSSO, but Le Fort I surgery was not different from the other methods. In general, increasing the surgical time increased the amount of blood lost and decreased hemoglobin. The results of this study can be used in clinical planning of orthognathic surgery, and with optimal time management and preoperative prophylaxis and preparation for blood transfusion, especially in individuals and techniques with a higher risk of bleeding, it can lead to improved surgical outcomes and reduced complications due to decreased hemoglobin.
Appreciation and thanks
This article is extracted from the research project (724135728) which was implemented under the support of Babol University of Medical Sciences. We would like to express our gratitude to all the operating room staff of Shahid Beheshti Hospital of Babol and Dr. Shariati Hospital of Tehran who helped us in this research.
Conflict of interest
The authors reported no conflicts of interest.
References
1. Salma ReG, Al-Shammari FM, Al-Garni BA, Al-Qarzaee MA. Operative time, blood loss, hemoglobin drop, blood transfusion, and hospital stay in orthognathic surgery. Oral and Maxillofacial Surgery. 2017;21:259-66.
2. Steel BJ, Cope MR. Unusual and rare complications of orthognathic surgery: a literature review. Journal of oral and maxillofacial surgery. 2012;70(7):1678-91.
3. Schwaiger M, Wallner J, Edmondson SJ, Mischak I, Rabensteiner J, Gary T, et al. Is there a hidden blood loss in orthognathic surgery and should it be considered? Results of a prospective cohort study. Journal of Cranio-Maxillofacial Surgery. 2021;49(7):545-55.
4. Schneider KM, Altay MA, Demko C, Atencio I, Baur DA, Quereshy FA. Predictors of blood loss during orthognathic surgery: outcomes from a teaching institution. Oral and maxillofacial surgery. 2015;19:361-7.
5. Piñeiro-Aguilar A, Somoza-Martín M, Gandara-Rey JM, García-García A. Blood loss in orthognathic surgery: a systematic review. Journal of Oral and Maxillofacial Surgery. 2011;69(3):885-92.
6. Thastum M, Andersen K, Rude K, Nørholt SE, Blomlöf J. Factors influencing intraoperative blood loss in orthognathic surgery. International journal of oral and maxillofacial surgery. 2016;45(9):1070-3.
7. Olsen JJ, Ingerslev J, Thorn JJ, Pinholt EM, Gram JB, Sidelmann JJ. Can preoperative sex-related differences in hemostatic parameters predict bleeding in orthognathic surgery? Journal of Oral and Maxillofacial Surgery. 2016;74(8):1637-42.
8. Kretschmer W, Köster U, Dietz K, Zoder W, Wangerin K. Factors for intraoperative blood loss in bimaxillary osteotomies. Journal of oral and maxillofacial surgery. 2008;66(7):1399-403.
9. Ueki K, Marukawa K, Shimada M, Nakagawa K, Yamamoto E. The assessment of blood loss in orthognathic surgery for prognathia. Journal of Oral and Maxillofacial Surgery. 2005;63(3):4-350.
10. Shetty V. Effectiveness of intravenous haemocoagulase on haemorrhage control in bi-maxillary orthognathic surgery—a prospective, randomized, controlled, double-blind study. Journal of Cranio-Maxillofacial Surgery. 2015;43(10):2000-3.
11. Andersen K, Thastum M, Nørholt SE, Blomlöf J. Relative blood loss and operative time can predict length of stay following orthognathic surgery. International journal of oral and maxillofacial surgery. 2016;45(10):1209-12.
12. Stehrer R, Hingsammer L, Staudigl C, Hunger S, Malek M, Jacob M, et al. Machine learning based prediction of perioperative blood loss in orthognathic surgery. Journal of Cranio-Maxillofacial Surgery. 2019;47(11):1676-81.
13. Rummasak D, Apipan B, Kaewpradup P. Factors that determine intraoperative blood loss in bimaxillary osteotomies and the need for preoperative blood preparation. Journal of Oral and Maxillofacial Surgery. 2011;69(11):e456-e60.
14.Mirjani, Seyed Jaber, Attar S., Khosravi, Pour A. Study and comparison of the loss rateBlood donation during different types of orthognathic surgery. Journal of Mashhad Dental School. 2016;40(2):159-66.
15. Wu RT, Wilson AT, Gary CS, Steinbacher DM. Complete reoperation in orthognathic surgery. Plastic and Reconstructive Surgery. 2019;143(5):1053e-9e.
16. Ueki K, Marukawa K, Shimada M, Nakagawa K, Yamamoto E. The assessment of blood loss in orthognathic surgery for prognathia. Journal of Oral and Maxillofacial Surgery. 2005;63(3):4-350.
17. Bowe C, Gurney B, Sloane J, Johnson P, Newlands C. Operative time, length of stay and reoperation rates for orthognathic surgery. British Journal of Oral and Maxillofacial Surgery. 2021;59(2):163-7.